Artal Group S.A. - Q4 2021 holdings

$3.69 Billion is the total value of Artal Group S.A.'s 152 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 100.0% .

 Value Shares↓ Weighting
EQT ExitEQT CORP$0-9,678
-100.0%
-0.00%
ATUS ExitALTICE USA INCcl a$0-27,000
-100.0%
-0.01%
AVTR ExitAVANTOR INC$0-50,000
-100.0%
-0.05%
ExitOLAPLEX HLDGS INC$0-225,000
-100.0%
-0.12%
BPMC ExitBLUEPRINT MEDICINES CORP$0-100,000
-100.0%
-0.23%
DRNA ExitDICERNA PHARMACEUTICALS INC$0-700,000
-100.0%
-0.32%
BABA ExitALIBABA GROUP HLDG LTDsponsored ads$0-100,000
-100.0%
-0.33%
MRK ExitMERCK & CO INCcall$0-500,000
-100.0%
-0.84%
FCX ExitFREEPORT-MCMORAN INCcall$0-3,500,000
-100.0%
-2.55%
XLRN ExitACCELERON PHARMA INC$0-1,000,000
-100.0%
-3.85%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-02-11
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
AGENUS INC42Q3 20231.9%
IRONWOOD PHARMACEUTICALS INC42Q3 20230.3%
ALNYLAM PHARMACEUTICALS INC37Q3 20235.1%
LEXICON PHARMACEUTICALS INC34Q3 202320.6%
AMICUS THERAPEUTICS INC30Q3 20232.7%
BEIGENE LTD28Q3 20237.4%
BK OF AMERICA CORP28Q1 20214.3%
SAGE THERAPEUTICS INC28Q2 20231.9%
AGIOS PHARMACEUTICALS INC28Q2 20201.1%
NEKTAR THERAPEUTICS27Q2 20201.3%

View Artal Group S.A.'s complete holdings history.

Latest significant ownerships (13-D/G)
Artal Group S.A. Q4 2021 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
WEIGHT WATCHERS INTERNATIONAL INCFebruary 13, 201529,443,30051.9%

View Artal Group S.A.'s complete significant-ownership history.

Latest filings
TypeFiled
42024-06-07
13F-HR/A2024-05-17
42024-05-14
13F-HR2024-05-13
42024-03-25
42024-03-13
42024-02-29
13F-HR2024-02-09
13F-HR2023-11-13
42023-10-16

View Artal Group S.A.'s complete filings history.

Compare quarters

Export Artal Group S.A.'s holdings